HUT45045A - Process for producing at the 8 position substituted quinolone-carboxylic acid derivatives and pharmaceuticals comprising such compounds - Google Patents
Process for producing at the 8 position substituted quinolone-carboxylic acid derivatives and pharmaceuticals comprising such compoundsInfo
- Publication number
- HUT45045A HUT45045A HU87863A HU86387A HUT45045A HU T45045 A HUT45045 A HU T45045A HU 87863 A HU87863 A HU 87863A HU 86387 A HU86387 A HU 86387A HU T45045 A HUT45045 A HU T45045A
- Authority
- HU
- Hungary
- Prior art keywords
- pharmaceuticals
- compounds
- producing
- carboxylic acid
- acid derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP61045191A JPS62205060A (ja) | 1986-03-04 | 1986-03-04 | 8位置換キノロンカルボン酸誘導体 |
Publications (2)
Publication Number | Publication Date |
---|---|
HUT45045A true HUT45045A (en) | 1988-05-30 |
HU199821B HU199821B (en) | 1990-03-28 |
Family
ID=12712373
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU87863A HU199821B (en) | 1986-03-04 | 1987-03-03 | Process for production of derivatives of in 8 position substituated quinoline carbonic acid and medical compositions containing them |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0235762A1 (hu) |
JP (1) | JPS62205060A (hu) |
KR (1) | KR940007305B1 (hu) |
CN (1) | CN87101731A (hu) |
AU (1) | AU590055B2 (hu) |
HU (1) | HU199821B (hu) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0635457B2 (ja) * | 1985-06-28 | 1994-05-11 | 杏林製薬株式会社 | ピリドンカルボン酸誘導体およびその製造方法 |
EP0241206A3 (en) * | 1986-03-31 | 1989-05-10 | Sankyo Company Limited | Quinoline-3-carboxylic acid derivatives, their preparation and use |
DE3615767A1 (de) * | 1986-05-10 | 1987-11-12 | Bayer Ag | Verfahren zur herstellung von 4-hydroxy-chinolin-3-carbonsaeuren |
US5202231A (en) * | 1987-04-01 | 1993-04-13 | Drmanac Radoje T | Method of sequencing of genomes by hybridization of oligonucleotide probes |
EP0319906A3 (en) * | 1987-12-11 | 1990-05-02 | Dainippon Pharmaceutical Co., Ltd. | Novel quinoline derivatives, processes for preparation thereof and antibacterial agent containing them |
US5233091A (en) * | 1988-06-21 | 1993-08-03 | Pfizer Inc. | 6-fluoro-1,4-dihydroquinol-4-one-3-carboxylic acid derivatives and intermediates therefor |
US5103040A (en) * | 1988-06-21 | 1992-04-07 | Pfizer Inc. | 6-fluoro-1,4-dihydroquinol-4-one-3-carboxylic acid derivatives and intermediates therefor |
US5104868A (en) * | 1988-06-21 | 1992-04-14 | Pfizer Inc. | Tricyclic derivatives of 7-substituted-6-fluoro-1,4-dihydroquinol-4-one-3-carboxylic acids and esters |
US5039682A (en) * | 1988-06-21 | 1991-08-13 | Pfizer Inc. | 6-fluoro-1,4-dihydroquinol-4-one-3-carboxylic acid derivatives and intermediates therefor |
AU618823B2 (en) * | 1988-07-20 | 1992-01-09 | Sankyo Company Limited | 4-oxoquinoline-3-carboxylic acid derivatives, their preparation and their use |
CA1332605C (en) * | 1988-10-03 | 1994-10-18 | Yasuhiro Nishitani | Pyridonecarboxylic acids |
EP0997466A1 (en) * | 1988-10-24 | 2000-05-03 | PROCTER & GAMBLE PHARMACEUTICALS, INC. | Novel antimicrobial lactam-quinolones |
CA2001203C (en) * | 1988-10-24 | 2001-02-13 | Thomas P. Demuth, Jr. | Novel antimicrobial dithiocarbamoyl quinolones |
JP3449658B2 (ja) * | 1994-12-21 | 2003-09-22 | 杏林製薬株式会社 | 安定性に優れた8−アルコキシキノロンカルボン酸水和物並びにその製造方法 |
DE19652239A1 (de) | 1996-12-16 | 1998-06-18 | Bayer Ag | Verwendung von 7-(2-Oxa-5,8-diazabicyclo[4.3.0]non-8-yl)-chinolon- und -naphthyridoncarbonsäure-Derivaten zur Therapie von Helicobacter-pylori-Infektionen und den damit assoziierten gastroduodenalen Erkrankungen |
HUP0100051A3 (en) | 1997-09-15 | 2002-08-28 | Procter & Gamble | Antimicrobial quinolones, their compositions and uses |
US6387928B1 (en) | 1997-09-15 | 2002-05-14 | The Procter & Gamble Co. | Antimicrobial quinolones, their compositions and uses |
DE19751948A1 (de) * | 1997-11-24 | 1999-05-27 | Bayer Ag | Verfahren zur Herstellung von 8-Methoxy-Chinoloncarbonsäuren |
CN1091103C (zh) * | 1999-04-02 | 2002-09-18 | 中国科学院上海药物研究所 | 一类喹诺酮类化合物及它的制备和其用途 |
DE10337191A1 (de) * | 2003-08-13 | 2005-03-17 | Bayer Healthcare Ag | Neue Verwendung von Chinolon-Antibiotika |
ES2402420T3 (es) | 2003-09-29 | 2013-05-03 | Daiichi Sankyo Company, Limited | Derivado del ácido 8-cianoquinolonacarboxílico |
MX2008012488A (es) | 2006-03-28 | 2008-10-10 | Procter & Gamble | Un proceso de acoplamiento para preparar intermedios de quinolona. |
WO2007110836A1 (en) | 2006-03-28 | 2007-10-04 | The Procter & Gamble Company | A hydride reduction process for preparing quinolone intermediates |
ES2366150T3 (es) | 2006-03-28 | 2011-10-17 | Warner Chilcott Company, Llc | Malatos de polimorfos de ácido (3s,5s)-7-[3-amino-5-metil-piperidinil]-1-ciclopropil-1,4-dihidro-8-metoxi-4-oxo-3-quinolinocarboxílico. |
US20080139574A1 (en) | 2006-11-30 | 2008-06-12 | Cadila Healthcare Limited | Novel quinoline derivatives |
RU2616609C2 (ru) | 2011-11-08 | 2017-04-18 | Актелион Фармасьютиклз Лтд | Антибиотические производные 2-оксо-оксазолидин-3, 5-диила |
CN110551124B (zh) * | 2019-06-14 | 2021-01-08 | 山东省联合农药工业有限公司 | 一种喹诺酮类化合物或其农药学上可接受的盐及其制备方法与用途 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5630964A (en) * | 1979-08-22 | 1981-03-28 | Kyorin Pharmaceut Co Ltd | Novel substituted quinolinecarboxylic acid and its preparation |
IE55898B1 (en) * | 1982-09-09 | 1991-02-14 | Warner Lambert Co | Antibacterial agents |
AU553415B2 (en) * | 1983-09-19 | 1986-07-17 | Abbott Japan Co., Ltd. | 6-fluoro-1-4-dihydro-4-oxo-7-substituted piperazinyl- quinoline-3-carboxylic acids |
JPH0635457B2 (ja) * | 1985-06-28 | 1994-05-11 | 杏林製薬株式会社 | ピリドンカルボン酸誘導体およびその製造方法 |
-
1986
- 1986-03-04 JP JP61045191A patent/JPS62205060A/ja active Pending
-
1987
- 1987-02-27 EP EP87102815A patent/EP0235762A1/en not_active Withdrawn
- 1987-03-02 AU AU69590/87A patent/AU590055B2/en not_active Ceased
- 1987-03-03 KR KR1019870001868A patent/KR940007305B1/ko active IP Right Grant
- 1987-03-03 HU HU87863A patent/HU199821B/hu not_active IP Right Cessation
- 1987-03-04 CN CN198787101731A patent/CN87101731A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
JPS62205060A (ja) | 1987-09-09 |
KR870008846A (ko) | 1987-10-21 |
HU199821B (en) | 1990-03-28 |
AU6959087A (en) | 1987-09-10 |
EP0235762A1 (en) | 1987-09-09 |
CN87101731A (zh) | 1987-09-16 |
KR940007305B1 (ko) | 1994-08-12 |
AU590055B2 (en) | 1989-10-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUT45045A (en) | Process for producing at the 8 position substituted quinolone-carboxylic acid derivatives and pharmaceuticals comprising such compounds | |
HUT50339A (en) | Process for producing benzoxazole derivatives and pharmaceutical compositions comprising the compounds | |
HU912420D0 (en) | Process for producing 9(11)-dehydro-steroid derivatives | |
HU906465D0 (en) | Process for producing 3 beta-/4(s)-aryl-oxazolidine-2-one-3-il/-azetidine-2-one derivatives | |
KR950010075B1 (en) | Process for the preparation of 1,2,3,6-tetrahydro-5-nitro-pyrimidine derivatives | |
HUT48624A (en) | Process for producing 6-benzoxazinyl- and 6-benzothiazinyl-2,3,4,5-tetrahydropyridazin-3-ones and pharmaceutical compositions comprising such compounds | |
HUT35687A (en) | Improved process for producing cepheme-carboxylic acid derivatives containing two-cyclic pyridinium-methyl group at the 3 position | |
HU901428D0 (en) | Process for the preparation of 5-substituted 1,4-dihydro-4-oxo-naphthiridine-3-carboxylic acid derivatives | |
PT82384B (en) | Process for preparing substituted 2,3,4,9-tetra-hydro-1h-carbazole-1-acetic acid derivatives | |
HU902995D0 (en) | Process for the preparation of oxophthalazinyl-acetic acid derivatives | |
EP0337176A3 (en) | Novel benzoic acid derivatives and process for preparing the same | |
ZA858195B (en) | 1,2,4-triazolo-carbamates and the acid addition salts thereof,processes for preparing them and pharmaceutical compositions | |
GB2158433B (en) | Sialic acid derivatives and process for the preparation thereof | |
HUT45248A (en) | Process for producing 8alpha-(acylamino)-ergoline derivatives and pharmaceuticals comprising such compounds | |
SG11288G (en) | N-acytylneuraminic acid derivatives and process for the preparation thereof | |
HUT44242A (en) | Process for preparing substituted toluidine-benzimidazole derivatives and pharmaceuticals comprising such compounds | |
KR0156581B1 (en) | 1,4-benzothiazine-2-acetic acid derivatives and process for production | |
EP0371492A3 (en) | Process for the preparation of 1,4-dihydropyridine derivatives | |
GR3001052T3 (en) | Novel 16,17-acetalsubstituted pregnane-21-oic acid derivatives, process for the preparation thereof and pharmaceutical preparation containing them | |
PT83884B (en) | Process for the preparation of 1 azolyl-3,3-dimethyl-tutan-2-on-and-ol derivatives | |
EP0239015A3 (en) | Process for producing 1-beta-d-arabinofuranosylcytosine-5'-stearylphosphate monosodium salt and monohydrate thereof, and pharmaceutical composition containing the latter | |
CY1760A (en) | Process for the preparation of 1,4-dihydropyridine derivatives | |
GB2272218B (en) | Process for the preparation of 2,4,6-triiodo-isophthalic acid bis-(1,3-dihydroxypropylamide) derivatives | |
HUT37591A (en) | Process for preparing /1,3-dioxi-1,3-propane-diil/-diimino/ -bis-benzoic acid and its derivatives | |
HUT45261A (en) | Process for producing 7-oxo-4-thia-1-aza-bicyclo/3.2.0/-hept-2-ene derivatives and pharmaceutical compositions containing them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
HU90 | Patent valid on 900628 | ||
HMM4 | Cancellation of final prot. due to non-payment of fee |